Pharma & Healthcare · Q1 FY27 results
Sector in the results season
Pharma & Healthcare · Q1 FY27 results
final · 257 of 258 results
257
of 258 results
43%
very good + good, of 251 rated
+15.8%
median YoY, n=189
-0.8%
median, n=247
Numbers
Profit up at 119 of 189 (63.0%) · growing faster than 15%: 101 (53.4%) · Median excludes extremes: revenue 0, profit 5
Reports
Reaction
Median day-1 move 0.8% · 100 up, 141 down of 247 priced
StockWatch Result Rating is our own rating of the reported quarter, not of the stock; counts are of quarters rated so far.
Growth: year-on-year vs the same quarter of Q1 FY26, one basis per company (consolidated where both years report it, else standalone); banks, financial services and insurers by total income. Aggregate = growth of the summed values; median = the middle company. A company whose prior-year profit was a loss has no profit growth figure.
Day-1 reaction = the stock's move on the first session after the result, % vs the last close before it; medians are over quarters with a priced reaction.
Sectors are the 13 StockWatch groups; 365 quarters (diversified or unclassified companies) count in the totals but in no sector.
Size bands by market-cap rank across all listed companies we track: large = top 100, mid = 101-250, small = the rest.
Updated 14 Oct 2026, 05:00 am












































